세계의 무바늘 당뇨병 치료 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 장치 유형별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)

The global Needle-Free Diabetes Care market was valued at USD 13.51 billion in 2024 and is expected to experience significant growth during the forecast period, with a projected compound annual growth rate (CAGR) of 5.90% through 2030. This market focuses on providing alternatives to traditional insulin injection methods for the management of diabetes, offering more convenient and less painful options for individuals with diabetes.

Key Market Drivers:

Rising Prevalence of Diabetes

The increasing prevalence of diabetes is largely driven by factors such as sedentary lifestyles, poor dietary habits, and an aging population. This growing global health concern not only impacts individual health but also places a substantial strain on healthcare systems and economies. According to the World Health Organization (WHO), diabetes is a chronic condition characterized by elevated blood glucose levels, which can lead to severe complications. Over 830 million people worldwide are affected by diabetes, with a significant proportion living in low- and middle-income countries. Diabetes management is shifting from a physician-centered model to a more patient-centric approach. Patients now seek solutions that offer greater convenience, reduce pain, and improve their quality of life. As traditional insulin injections are often seen as uncomfortable and inconvenient, there is an increasing demand for needle-free alternatives.

Key Market Challenges:

Regulatory Approvals

One of the key challenges in the needle-free diabetes care market is the need for regulatory approvals for new devices and technologies. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict safety and efficacy standards, making the approval process time-consuming and costly for manufacturers. These regulatory hurdles can delay the introduction of new products into the market.

Key Market Trends:

Closed-Loop Systems

Closed-loop insulin delivery systems, often referred to as artificial pancreases, are gaining popularity in the diabetes care market. These systems automatically adjust insulin delivery based on continuous glucose monitoring (CGM) data, providing users with better control over their blood glucose levels. As technology continues to evolve, closed-loop systems are expected to become more accessible, user-friendly, and effective.

Key Market Players:

• 3M Co
• Bioject Medical Technologies Inc
• Valeritas Inc
• Antares Pharma Inc
• Endo International PLC
• InsuJet
• PharmaJet Inc
• INJEX Pharma AG
• Johnson & Johnson
• MannKind Corp

Report Scope:

This report segments the global Needle-Free Diabetes Care market into the following categories, while also providing insights into key industry trends:

By Device Type:

• Insulin Infusers
• Insulin Patches
• Insulin Pens
• Insulin Pumps
• Jet Injectors

By End-User:

• Homecare
• Diagnostic Centers
• Hospitals & Clinics

By Region:

• North America: United States, Canada, Mexico
• Europe: Germany, United Kingdom, France, Italy, Spain
• Asia-Pacific: China, Japan, India, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait

Competitive Landscape and Company Profiles:

This section provides an in-depth analysis of the major players operating in the global Needle-Free Diabetes Care market.

Available Customizations:

TechSci Research offers customized reports based on specific market data for the global Needle-Free Diabetes Care market. The following customization options are available:

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Needle Free Diabetes Care Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 5.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Device Type
  • 5.3.2. By End User
  • 5.3.3. By Region

6. North America Needle Free Diabetes Care Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 6.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Needle Free Diabetes Care Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Needle Free Diabetes Care Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Needle Free Diabetes Care Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By End User

7. Europe Needle Free Diabetes Care Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 7.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Needle Free Diabetes Care Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Needle Free Diabetes Care Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By End User
  • 7.3.3. France Needle Free Diabetes Care Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Needle Free Diabetes Care Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Needle Free Diabetes Care Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Needle Free Diabetes Care Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 8.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Needle Free Diabetes Care Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Japan Needle Free Diabetes Care Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By End User
  • 8.3.3. India Needle Free Diabetes Care Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By End User
  • 8.3.4. Australia Needle Free Diabetes Care Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By End User
  • 8.3.5. South Korea Needle Free Diabetes Care Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By End User

9. South America Needle Free Diabetes Care Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 9.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Needle Free Diabetes Care Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Needle Free Diabetes Care Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Needle Free Diabetes Care Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Needle Free Diabetes Care Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 10.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Needle Free Diabetes Care Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Needle Free Diabetes Care Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Needle Free Diabetes Care Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By End User
  • 10.3.4. Kuwait Needle Free Diabetes Care Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Device Type
      • 10.3.4.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. 3M Co
• 14.2. Bioject Medical Technologies Inc
• 14.3. Valeritas Inc
• 14.4. Antares Pharma Inc
• 14.5. Endo International PLC
• 14.6. InsuJet
• 14.7. Pharmajet Inc
• 14.8. INJEX Pharma AG
• 14.9. Johnson & Johnson
• 14.10.MannKind Corp

15. Strategic Recommendations

16. About Us & Disclaimer